Hosted on MSN33m
Regeneron’s (NASDAQ:REGN) Q4 Sales Top Estimates, Stock SoarsBiotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results , with sales up 10.3% year on year to $3.79 billion. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback